MEDIcept Minute: Upcoming FDA Town Hall: Medical Device Sterilization Updates Stay ahead in sterilization! On Wednesday, December 4, 2024, from 2:00–3:30 PM ET, the FDA will host the final session in their Medical Device Sterilization Town Hall Series. This virtual event will discuss key updates, including the new Transitional Enforcement Policy for Ethylene Oxide (EtO) Sterilization Changes for Class III Devices and research on vaporized hydrogen peroxide (VH202) diffusion through polymeric materials. The session will also wrap up the series, highlighting its industry impact and outlining future steps to advance sterilization practices. Submit your questions by Monday, December 2, 2024, at 4:00 PM ET to [email protected]. Learn more about the town hall at the link below. https://lnkd.in/ec5G3WyR Sterilization plays a vital role in patient safety and compliance. If you need expert support navigating these regulatory updates, contact MEDIcept Inc. today at [email protected]! #FDA #MedicalDevices #Sterilization #EthyleneOxide #VH202 #RegulatoryUpdates #Compliance ?
MEDIcept Inc.
商务咨询服务
Boston,MA 12,058 位关注者
Global Medtech Clinical, Regulatory, Reimbursement, Compliance & Quality Consultancy
关于我们
MEDIcept strives to provide our clients with proven, trusted, and cost-effective solutions. We are an international medical device, IVD, combination product, and biotechnology compliance consulting firm. For over 25 years, our unique consulting practice has assisted thousands of companies of all sizes with cost-effective Regulatory, Quality, Clinical, Auditing, and Educational services. Our experienced team of former FDA, Notified Body, and industry experts will work with you to efficiently develop or remediate a quality system, create a regulatory strategy, or establish a clinical trial, to meet your specific needs. MEDIcept will help you navigate the complex FDA and international regulatory pathways, reduce business risk, and decrease time-to-market while maximizing your potential for success. Every client and every issue is unique. We customize our solutions to fit your needs. With a retention rate of over 90%, we can promise that you will benefit from working with us.
- 网站
-
https://www.medicept.com
MEDIcept Inc.的外部链接
- 所属行业
- 商务咨询服务
- 规模
- 11-50 人
- 总部
- Boston,MA
- 类型
- 私人持股
- 创立
- 1996
- 领域
- Clinical、Regulatory、Quality、Engineering Support、Clinical Research Organization、Regulatory Submissions、Global Regulatory Strategy、Audits、Quality Management Systems、Risk Management、ISO 13485、FDA、Invitro Diagnostic、Medical Device、Remediation、Validation、Software、MDSAP、Design Control、Training、CAPA、Due Diligence、Interim Professionals、Cybersecurity、483/Warning Letter Response、MDD/MDR、Regulatory Registration和CRO
地点
MEDIcept Inc.员工
动态
-
Happy Thanksgiving from MEDIcept Inc.! We're thankful for each of you! #HappyThanksgiving #Thanksgiving #Thankful
-
MEDIcept White Paper: Selecting the Right EDC for your Clinical Trial - The Difference in Device Approval Dive into the world of clinical trials with our latest White Paper! Discover why selecting the right Electronic Data Capture (EDC) system is crucial for your trial’s success. From enhancing data security to improving user experience, we explore the key factors that make a difference in device approval.? Our white paper delves into the evolution of EDC systems and their critical role in modern clinical trials. Learn how selecting the right EDC system can make or break your trial's success. Join us in exploring the future of trial management! Read the White Paper written by the Clinical team, by clicking the link below.? https://lnkd.in/e3TB4vj7 MEDIcept Inc. has a skilled CRO who would be glad to assist you with your EDC selection process and clinical strategy. Email us today at [email protected] to learn more about how we can assist you. #ClinicalTrials #EDC #DataManagement #MedicalDevices #HealthcareTech?
-
MEDIcept Inc. is excited to speak on "Risky Business: Taming Your Risk Management System" at the upcoming ASQ New England Discussion Group?Meeting. The discussion group takes place December 10th from 4-8pm in Waltham, MA. By attending this event, you'll hear from three MEDIcept subject matter experts. They will be joined by Diane Shay, Vice President of Quality,?Interative Scopes. They will discuss how you can be certain your risk management process meets current regulatory requirements, and more! To learn more about this event and to register, click the link below. https://lnkd.in/e6ATgvUK Not attending the event but still interested in learning how MEDIcept Inc. can help tame your risk management system? Email [email protected] to set up a virtual meeting. #riskmanagement #risksystem #medicaldevices #riskprocess #regulatory #requirements #speakers
-
MEDIcept Minute: Stay Ahead with FDA eSTAR: Version 5.4 Released! FDA eSTAR Update Alert! ?Earlier this week, FDA released Version 5.4 of the eSTAR tool. Ensure your medical device submissions meet requirements by reviewing the updated version history and device description help text—critical for avoiding technical screening deficiencies. With the mandatory use of eSTAR for 510(k) submissions already in effect, and De Novo submissions required by October 2025, staying current is key. eSTAR simplifies the process with automation, standardization, and built-in forms to streamline regulatory compliance. Don’t let technical oversights delay your submission! Read more about this update from FDA at the link below. https://lnkd.in/gPnEXjgW Need expert assistance with your eSTAR submissions? Contact MEDIcept Inc. today at [email protected]?for seamless regulatory support! #FDA #eSTAR #MedicalDevices #RegulatoryUpdates?
-
Unlocking Success in Regulatory Compliance: POLARIS??'s Journey to FDA 510(k) Clearance with MEDIcept Consulting Experts We are excited to announce the release of our latest case study showcasing how MEDIcept guided PolarisAR Inc. through the complex regulatory landscape to achieve FDA 510(k) clearance for their groundbreaking STELLAR Knee augmented reality technology. By engaging MEDIcept’s regulatory experts early in the process, we helped streamline their submission and respond efficiently to FDA feedback, significantly reducing time to market. This collaboration not only ensured compliance but also empowered the POLARIS?? team with essential skills for future success. To dive deeper into the details of this successful partnership and learn more about the challenges and solutions, visit our website at the link below to read the full case study. https://lnkd.in/dUhYjhzT Are you navigating regulatory challenges in your innovation journey? Contact MEDIcept Inc. today at [email protected] to learn how we can support your needs! #CaseStudy #PolarisAR #MedicalDevices #FDA #CustomerSuccessStory
-
That's a wrap on the 2024 MEDevice Silicon Valley Conference! MEDIcept Inc. was well represented by our President, F. David Rothkopf and Senior Software Quality Engineer, Gregg V.. If you attended the conference, we hope you were able to attend their sessions and connect afterwords. If you were not in attendance but want to connect with David, Gregg, and the rest of our team, email us today at [email protected]. #MEDevice #SiliconValley #MedicalDevices #Regulatory #Quality #Software
-
REMINDER: Upcoming FDA Webinar: Key Updates on IVD and LDT Regulations On December 3, 2024, the FDA will host a webinar to outline critical information regarding the registration and listing requirements for In Vitro Diagnostic Products (IVDs), including Laboratory Developed Tests (LDTs). This follows the FDA’s May 2024 final rule, clarifying that IVDs are considered devices under the FD&C Act, even when manufactured by laboratories. With compliance expected by May 2025, now is the time to understand how these regulations will impact your operations. Visit the link below to learn more about how you can attend the webinar. https://lnkd.in/gdir3Ce7 Don’t miss this chance to prepare your team and ensure compliance. For personalized regulatory support, contact MEDIcept Inc. today at [email protected]. #MedicalDeviceRegulations #IVDCompliance #LDTs #FDAWebinar #RegulatoryAffairs?
-
MEDIcept Minute: FDA Final Guidance on 510(k) - Third Party Review Program and EUA Review Released! The U.S. Food and Drug Administration (FDA) has issued its final guidance for the 510(k) Third Party Review Program and Third Party Emergency Use Authorization (EUA) Review. This document clarifies the FDA's expectations, eligibility criteria, and processes for third-party review organizations to support streamlined reviews of 510(k) submissions and EUA requests during public health emergencies. Key highlights include: -Clear FDA expectations for 510(k) and EUA third-party reviews? -Detailed eligibility criteria and procedures for third-party review organizations? -Emphasis on quality, consistency, and conflict prevention? -Insights into compensation processes This guidance represents a significant step in enhancing efficiency and ensuring high-quality regulatory reviews. Read more about this new guidance from the FDA at the link below. https://lnkd.in/gePaN6QF Have questions or need support navigating these updates? Contact MEDIcept Inc. at [email protected] today for expert guidance. #FDA #510k #ThirdPartyReview #MedicalDevices ?
-
Navigating FDA Clearance: Sira Medical's Success Story with MEDIcept We are thrilled to announce the successful FDA 510(k) clearance of Sira Medical's innovative augmented reality (AR) preoperative surgical planning application! Our dedicated team at MEDIcept provided essential regulatory guidance, cybersecurity expertise, and usability testing support, ensuring a seamless submission process. This collaboration not only empowered Sira Medical with a clearer understanding of FDA requirements but also positioned them for revenue growth and future funding. To read more about this success story, visit our website at the link below: https://lnkd.in/eB76EA48 Are you navigating the complexities of FDA submissions? Contact MEDIcept Inc. today at [email protected] to learn how we can support your regulatory needs! #FDA #510k #RegulatoryAffairs #MedicalDevice #AugmentedReality #MEDIcept #SuccessStory #HealthcareInnovation